PPAR activation Clinical evidence
Lancet 373:1765-72, 2009
Are We Nearing the Limits of Office-Based CV Prevention? Thomas G. Allison, PhD, MPH.
Lancet 373:1765-72, 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.
